In eubacteria that lack glutaminyl-tRNA synthetase (GlnRS), a tRNA-dependent amidotransferase (GatCAB) recognizes mischarged Glu-tRNA Gln and converts it into Gln-tRNA
Introduction
A tRNA-dependent amidotransferase (GatCAB) plays an important role in eubacteria that lack glutaminyl-tRNA synthetase (GlnRS) (Wilcox and Nirenberg, 1968 , Schön et al., 1988 , Ibba et al., 1999 . In these bacteria, tRNA
Gln is first misaminoacylated with glutamate by a non-discriminating glutamyl-tRNA synthetase (ndGluRS), which, in addition to generating Glu-tRNA Glu , also forms Glu-tRNA
Gln
. The resulting mischarged tRNA is then recognized by GatCAB and converted into Gln-tRNA Gln (Wilcox, M., 1968 , Curnow et al., 1997 , Ibba et al., 2000 . Therefore, the inhibition of GatCAB might result in growth repression or lethality in these bacteria, in which case a GatCAB inhibitor could be used as a drug that has a novel target and mode of action.
New targeted antimicrobial agents are urgently required to combat pathogens such as
Staphylococcus aureus that have acquired multidrug resistance. Whole-cell bioassays involving S. aureus cannot effectively screen for inhibitors specific for GatCAB as various compounds affect the growth of bacteria in a variety of ways. An in vitro assay would require the preparation of a large amount of Glu-tRNA Gln , the substrate for GatCAB, which would be both time-consuming and costly. To screen a new GatCAB inhibitor from thousands of chemical compounds or natural products, it is important to construct a simple method to evaluate the inhibition of this enzyme. Moreover, a recent study showed that a non-discriminating aspartyl-tRNA synthetase (ndAspRS), tRNA
Asn
, and a tRNA-dependent amidotranseferase, assemble into a specific ribonucleoprotein complex, the transamidosome, that remains stable during the overall catalytic process (Bailly et al., 2007) .
It remains unclear whether or not ndGluRS, Glu-tRNA Gln and GatCAB also assemble into a similar complex. Regardless, a bioassay monitoring the growth repression of living cells due to inhibition of the whole transamidosome is both more practical and specific than an in vitro assay for GatCAB activity.
In Bacillus subtilis, a single ndGluRS is responsible for the aminoacylation of both tRNA Gln and tRNA Glu with glutamate. This enzyme can also mischarge Escherichia coli tRNA 1 Gln with glutamate, but not E. coli tRNA 2 Gln and tRNA Glu in vitro (Lapointe et al., 1986) . Early attempts to clone the B. subtilis ndGluRS gene in E. coli were unsuccessful. Over-expression of an intact B. subtilis ndGluRS was found to be lethal in E. coli (Pelchat et al., 1998) . A controlled vector system using B. subtilis ndGluRS expression in E. coli verified that reduced numbers of colony formation units in the E. coli was due to the mischarging of tRNA Gln with glutamate (Baick et al., 2004) .
In this work, we describe a new system for monitoring GatCAB inhibition in E. coli Top10 in which both the ndGluRS and GatCAB genes from Staphylococcus aureus Mu50 are expressed in the presence and in the absence of chemical compound or natural product of interest, and compared the growth of these bacteria. The design and strategy of the system is shown in Fig.1 . We first confirmed that growth repression was induced by the expression of ndgluRS from S. aureus Mu50 in E. coli. Then, we verified that co-expression of the gatCAB operon alleviated growth repression by ndGluRS in the host E. coli. In addition, two
GatCAB deletion variants, GatCAB
Δ10
and GatCAB
ΔCHD
, containing the deletion of the entire helical bundle domain and the deletion of 64 residues from the C terminus of GatB respectively, were expressed in E. coli together with ndGluRS. It was already known that these deletion variants are incapable of binding tRNA, as shown by an in vitro gel-shift assay (Nakamura et al., 2006) . We assumed that the two expressed GatCAB deletion variants were also inactive, and could not alleviate growth repression in E. coli. We therefore expressed inactive GatCABs in E. coli, since no chemical inhibitor presently exists.
The growth of the transformants was measured and compared to that of the control, ndGluRS and GatCAB co-expressed E. coli.
Materials and Methods

Bacterial strains
The bacterial strains, Escherichia coli XL10Gold (Stratagene, La Jolla, Calif, USA) and E.
coli Top10 (Invitrogen Corp., Carsbad, CA, USA), were used for general manipulation and propagation of plasmids. E. coli Top10 was used as a host strain for the expression of the ndGluRS gene and the gatCAB operon from Staphylococcus aureus Mu50.
DNA and vector construction
The plasmids used or constructed in this study are shown in Fig. 2 , and the primer sequences are listed in Table 1 . The entire ndGluRS gene from Staphylococcus aureus Mu50 was polymerase chain reaction (PCR) amplified using the primer pair of ndGluRS-f-Ncol and ndGluRS-rXbal. The gene was then cloned into the NcoI/XbaI site of pBAD/ Myc-His B vector (Invitrogen) to construct pBADndgluRS. The gatCAB operon from pET-28/gatCAB (Nakamura et al., 2006) was PCR amplified using the primer pair GatC-f-Ncol and GatB-lumio-r-Xhol. The operon was then cloned first into the NcoI/Xhol site of pCOLADuet-1 (Novagen®, Darmstadt, Germany), with the ColA origin, fused with a linker and the lumio tag (Cys-Cys-Pro-Gly-Cys-Cys) at the C-terminus of GatB.
The lumio tag fused gatCAB operon was PCR amplified using the primer pair gat C-f-Ncol and lumio-r-Kpnl, and cloned into the NcoI/Kpnl site of pTrcHis2A (Invitrogen) to obtain a trc promoter element. Then, together with the trc promoter region and terminator, the gatCAB operon with the lumio tag was PCR amplified using the primer pair pTrc-f-BamHl and rrnB-r-Xhol, and cloned back into the BamHI/XhoI site of pCOLADuet-1 to form pCTgatCAB.
Because of the different origin of replication, plasmids derived from pCOLADuet-1 are compatible with the pBAD/Myc-His B derivative. Each insertion of plasmid was sequenced to confirm the construct.
DNA manipulation and transformation
The standard procedures were as described in Molecular Cloning (Sambrook and Russell, 2001 ). All plasmids were extracted using GE Healthcare illustra plasmid prep Mini Spin kit (GE Healthcare, USA). Restriction enzymes were purchased from Takara Bio Ohtsu, Japan. Dephosphorylation was performed with Takara alkaline phosphatase (Takara Bio, Ohtsu, Japan). A T4 DNA ligation kit ver.2 (Takara Bio) was used for ligation. Transformation was achieved by electroporation using a Gene pulser II electroporation system (Bio-Rad, California, USA).
PCR and sequencing
For the amplification of genes and DNA fragments, KOD DNA polymerase-plus ver.2 (Toyobo, Osaka, Japan) was used. All sequencing reactions were conducted using a BigDye Terminator v1.1 cycle sequencing kit, and the products were analyzed by an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA) 2.5. Co-expression of ndGluRS and GatCAB in E. coli Top10
Transformant E. coli Top10/pBADndgluRS/pCTgatCAB cells were grown at 30°C in LB medium containing 50 μg/mL each kanamycin and carbenicillin. The expression of ndGluRS was induced by initially adding 0.2% L-arabinose under constitutively co-expressed GatCAB.
After running the cell lysate on an SDS polyacrylamide gel, the expression of ndGluRS was detected by western blotting using anti-His Antibody (Invitrogen), as described in the manufacturer's protocol. 
Results
3.1.
Growth inhibition by the expression of pBADndgluRS and its alleviation by co-expression of GatCAB in E. coli TOP10
We constructed two plasmids, pBADndgluRS and pCTgatCAB, which harbor the ndGluRS gene and the GatCAB gene operon, respectively. E. coli RNA polymerase can transcribe both genes. The pBADndgluRS, which strictly regulates the expression of ndGluRS under the araBAD promoter (Guzman et al., 1995) , was transformed into E. coli Top10 together with pCTgatCAB． When E. coli Top10 /pBADndgluRS/pCOLADuet-1 was incubated in the presence of 0.2% L-arabinose (without pCTgatCAB), ndGluRS was expressed after 6 h incubation, but expression decreased at 9h (Fig. 3, B) . The growth of the bacteria was repressed throughout the incubation period (Fig. 4) . In contrast, the expression of both ndGluRS and GatCAB in E. coli Top10 /pBADndgluRS/pCTgatCAB with 0.2% L-arabinose was confirmed after 3 hrs incubation (Fig. 3, A, B) . The total growth and the viable cell counts of the strain were higher than that of ndGluRS alone expressed bacteria.
Presumably constitutively expressed GatCAB alleviated the lethality of ndGluRS products (Fig. 3, A , B, and Fig.4) . GatCAB was stably expressed under the trc promoter, probably without lacI q expression and without IPTG induction. Moreover, ndGluRS expression was also increased by the addition of L-arabinose with GatCAB co-expression (Fig.3, A, B ).
Damaged and living microbial cells after 6h incubation were discriminated by fluorescence microscopy using two fluorescence dyes. The bacteria with intact cell membranes stained fluorescent green with SYTO9, whereas bacteria with damaged membranes stained fluorescent orange with propidium iodide (Fig. 5, A) . The survival rate of cells co-expressed with GatCAB, as well as non-induced cells, was about 10 times higher than that of GluRS expressed cells alone (Fig. 5, B) . These results demonstrated that ndGluRS from
Staphylococcus aureus Mu50 produced Glu-tRNA 1 Gln in E. coli Top10, and co-expressed
GatCAB from Staphylococcus aureus Mu50 also alleviated the lethal effect of Glu-tRNA 1
Gln in E. coli Top10.
The O.D. values in the three types E. coli Top10 (i.e., non-induced, ndGluRS expressed, and both ndGluRS and gatCAB expressed), after 6h incubation were highly reproducible.
Based on the difference in O.D. values between ndGluRS expressed E. coli, and ndGluRS
and gatCAB co-expressed E. coli, we constructed a screening system for monitoring inhibition specific for GatCAB activity. In this system, two types of transformants, E. coli Therefore, Glu-tRNA 1 Gln produced by ndGluRS would not be converted to Gln-tRNA 1 Gln , thereby repressing growth.
Activities of GatCAB deletion variants in E. coli Top10
In the constructed system, we expressed inactive gatCABs in E. coli, since adding an inhibitor was not possible, as none presently exist. The time course of total growth of the transformants was measured and compared to that of controls. Although GatCAB ΔCHD and GatCAB
Δ10
were co-expressed as proteins together with ndGluRS (Fig. 6, A and B) , the transformants harboring GatB deletion mutants (10 and CHD in Fig. 6 , C) showed a lower growth rate than ndGluRS and GatCAB co-expressed E. coli (Co in Fig. 6 , C) as well as ndGluRS expressed E. coli (RS in Fig. 6, C ). These results demonstrate that the Glu-tRNA 1 Gln produced by ndGluRS could not be converted to Gln-tRNA 1 Gln by GatCAB ΔCHD and GatCAB
in this system. Therefore, if a compound inhibited GatCAB activity in ndGluRS and GatCAB co-expressed E. coli Top10, the co-expressed E. coli could no longer grow as quickly as the control, resulting in decreased growth rate and lower O.D.
Discussions
We have developed a simple turbidimetric method for monitoring the inhibition of S. GatCAB is a heterotrimeric protein composed of A, B, and C subunits. GatCAB catalyzes three reactions: GatA acts as a glutaminase, and GatB acts as both a kinase and transamidase. These reactions are tightly coupled, and the binding of Glu-tRNA Gln regulates the glutaminase reaction (Nakamura, et al., 2006) . In order to screen for inhibitors specific for this coupling reaction, we established a screening system using E. coli Top10 /pBADndgluRS /pCTgatCAB, E. coli Top10 /pBADndgluRS /pCOLADuet-1 and non-inductive E. coli Top10. A compound that can decrease the growth of co-expressed E.
coli Top10 /pBADndgluRS /pCTgatCAB, but not that of the non-inducer, could be an inhibitor specific for GatCAB. Such screening is now in progress in our laboratory using culture supernatants from various isolates, as well as synthesized chemical compounds. Because E.
coli cells produce enzymes, S. aureus-nuGluRS and S. aureus-GatCAB and substrate for GatCAB in this system, it could be important for a specific inhibitor to be transported through the membrane. araBAD: araBAD promoter, T7: T7 promoter, trc: trc promoter Source or references for each plasmid are described in the manuscript.
Primers and their sequences are listed in Table 1 . 
